Professor of Pediatrics, Case West Res University

Pediatric Hematology & Oncology

Doctor Gregory E. Plautz, MD works in the field of Pediatric Hematology & Oncology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. He over the years received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Doctor Gregory E. Plautz, MD has written publications. He has 13 publications published with PubMed. The lastest publication is: 'Chylopericardium and chylothorax: Unusual mechanical complications of central venous catheters.'

Publications

---

• Chylopericardium and chylothorax: Unusual mechanical complications of central venous catheters.
• Metastatic osteoSarcoma to the stomach and ascending colon in a pediatric patient causing gastrointestinal hemorrhage.
• T Cells sensitized with breast tumor progenitor Cell vaccine have therapeutic activity against spontaneous HER2/neu tumors.
• Tumor-primed, in vitro-activated CD4+ effector T Cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure.
• Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector Cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitu...
• Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.
• Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells.
• Active immunotherapy for advanced intracranial murine tumors by using dendritic Cell-tumor Cell fusion vaccines.
• Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T Cells.
• Memory T cells originate from adoptively transferred effectors and reconstituting Host cells after sequential lymphodepletion and adoptive immunotherapy.
• Tumor-induced L-selectinhigh suppressor T Cells mediate potent effector T Cell blockade and cause failure of otherwise curative adoptive immunotherapy.
• Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion.

Schools

---

• Indiana University School of Medicine

• Johns Hopkins Hospital

• University Of Michigan

Procedures Preformed

---

• Plasmapheresis

Conditions Treated

---

• Acute Leukemia
• Anemia
• Deep Vein Thrombosis (DVT)
• Graft vs Host Disease
• View All

Doctors Specialties

---

• Pediatric Hematology
• Oncology

Accepted Insurances

---

Awards

---

• America's Top Doctors
• America's Top Doctors for Cancer

Education

---

• University of Michigan Hospitals and Health Centers
• Johns Hopkins University
• Indiana University School of Medicine

Hospital

---

• Cleveland Clinic

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Robin Norris, MD This Doctor is OpenDoctor Recommended.
	Dr. Ayman A. Saleh, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah W. Alexander, MD This Doctor is OpenDoctor Recommended.
	Dr. Wafa M. Al-Dhahir, MD This Doctor is OpenDoctor Recommended.
	Dr. Aron Flagg, MD This Doctor is OpenDoctor Recommended.
	Dr. Agne Petrosiute, MD This Doctor is OpenDoctor Recommended.
	Dr. Matteo M. Trucco, MD This Doctor is OpenDoctor Recommended.
	Dr. Eric D. Kodish, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Rachel A. Egler, MD This Doctor is OpenDoctor Recommended.
	Yousif H. Matloub, MB CHB This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog